Blockchain Registration Transaction Record
Cybin Expands Strategic Partnerships for Phase 3 Trial of CYB003 in Major Depressive Disorder
Cybin expands strategic partnerships for Phase 3 trial of CYB003 in major depressive disorder, signaling progress in revolutionizing mental healthcare with innovative treatment options for mental health conditions.

This news matters as Cybin's expansion of clinical sites for its psychedelic-based therapy trial signifies progress in revolutionizing mental healthcare. The strategic partnerships aim to provide innovative treatment options for those with mental health conditions, potentially offering hope to individuals suffering from major depressive disorder and generalized anxiety disorder.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xfbc10e71282484e1b343620c335c2502b6a3b86e7fdda8f6f0df01c3494c63bf |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | eachyxF7-14ff023f612b8a6781162733ad8d6c33 |